Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2008
09/04/2008US20080213256 Less Immunogenic Binding Molecules
09/04/2008US20080213255 Determining and reducing immunoresistance to a botulinum toxin therapy using botulinum toxin b peptides
09/04/2008US20080213251 Hexokinase specific immunoglobulin for use in treatment and prevention of asthma, chronic obstructive pulmonary disease, multiple sclerosis, psoriasis, rheumatoid arthritis, osteoarthritis, inflammatory bowel, immune mediated diabetes and pancreatic disorders
09/04/2008US20080213248 Methods and Systems for Treating Asthma and Other Respiratory Diseases
09/04/2008US20080213247 Mbms as Modifiers of Branching Morphogenesis and Methods of Use
09/04/2008US20080213245 Administering glutenase to Celiac or dermatitis herpetiformis patient reduces levels of toxic gluten oligopeptides; gene therapy
09/04/2008US20080213237 Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation Thereof
09/04/2008US20080213221 Providing mammalian cell contacted with agent and adeno-associated virus (AAV), identifying agent that when contacted with mammalian cell enhances AAV transduction after viral binding to membrane of contacted mammalian cell and before second strand synthesis which yields expressible form of viral genome
09/04/2008US20080213211 Compositions and methods for healthy pregnancy
09/04/2008US20080213184 A method of reducing or preventing a drug-related effect or behavior by inhibiting an N-type calcium channel and is directed toward drugs of abuse, such as, , ethanol, cannabinoids, and opioids; screening conotoxin modulators to effect sedative, hypnotic, ataxia and drug reward and consumption
09/04/2008US20080213179 Differentially Expressed Nucleic Acids in the Blood-Brain Barrier Under Inflammatory Conditions
09/04/2008US20080213171 Cancerous disease modifying antibodies
09/04/2008US20080213170 Isolated monoclonal antibody produced by the hybridoma; primary tumors and tumor metastases
09/04/2008US20080213169 Cytotoxicity mediation of cells evidencing surface expression of CD59
09/04/2008US20080213166 Novel Gene Targets and Ligands that Bind Thereto for Treatment and Diagnosis of Colon Carcinomas
09/04/2008US20080212842 Two Colour Vision System
09/04/2008US20080212070 Kit and method for multi-analyte determination
09/04/2008US20080211521 Moisture Content Sensor and Related Methods
09/04/2008US20080211518 Method and Apparatus for Measuring Electrical Conductivity
09/04/2008US20080211516 Method and Measuring Instrument for Measuring Water Content
09/04/2008US20080211485 Process for Identification of Compounds for Modulating the Activity of Sodium/Calcium Exchange Transporter
09/04/2008US20080211040 Semiconductor nanowire and deposited catalyst material; such as glucose level monitors for controlling insulin release
09/04/2008US20080210856 Fingerprinting of Complex Hydrocarbon Containing Mixtures
09/04/2008US20080210855 Method and Device for Determining the content of Lubricating Oil in an Exhaust Gas Mixture
09/04/2008US20080210104 Meat Processing Machine Comprising a Fat Analyzing Device
09/04/2008US20080209998 Yarn Testing Apparatus
09/04/2008US20080209996 Apparatus and Method for Quantitatively Measuring Liquid Film Drying Rates on Substrates
09/04/2008US20080209987 Measurement Instrument
09/04/2008US20080209982 Robust high temperature composite and co sensor made from such composite
09/04/2008US20080209709 Container uncapping mechanism and method
09/04/2008DE202008006634U1 Biosensor-Teststreifen und deren Vorratsbehälter Biosensor test strip and the reservoir
09/04/2008DE202007006107U1 Analysevorrichtung zur optischen Analyse eines Mediums mittels zumindest einer bildaufnehmenden Vorrichtung Analyzing apparatus for optical analysis of a medium by means of at least one image receiving device
09/04/2008DE102008006271A1 Target detection apparatus comprises a centrifuge with two containers, each containing a fluorescent particle and a fluorescence-quenching metal
09/04/2008DE102007010834A1 Method for in-vitro diagnosis or risk classification or outcome prognosis of heart failure for New york heart association patient, involves utilizing determination of marker proatrial natriuretic peptide
09/04/2008DE102007010046A1 PCa-Nachweisgerät Prostate cancer detection apparatus
09/04/2008DE102007009751A1 Diagnostic immunoassay for procalcitonin in a biological sample from a patient comprises selectively determining full-length procalcitonin 1-116
09/04/2008DE10031028B4 Verfahren zur Selektion von Partikeln A method for the selection of particles
09/04/2008CA2679570A1 Analysis of functional fluids using a redox indicator
09/04/2008CA2679435A1 Use of inhibitors of the degradation of p27, in particular argyrin and derivatives thereof, for the treatment of proliferative diseases
09/04/2008CA2679390A1 Modulation of sperm motility
09/04/2008CA2679334A1 Diagnostic detection device
09/04/2008CA2679325A1 Fatty acid synthase in liver disease
09/04/2008CA2679309A1 Reagent for quantitative determination of small, dense ldls
09/04/2008CA2679188A1 System and method for operating an electrochemical analyte sensor
09/04/2008CA2679179A1 Method for determining hydrophobic organic particles in a paper stock
09/04/2008CA2679062A1 Methods of treating infection
09/04/2008CA2678717A1 Imaging probes
09/04/2008CA2678583A1 Analysis of functional fluids
09/04/2008CA2678159A1 Ppar-gamma agonists for the induction of cationic antimicrobial peptide expression as immunoprotective stimulants
09/04/2008CA2677986A1 A method of identification of cells that show sensitivity to modulation of signaling mediated by a fibroblast growth factor receptor or a variant thereof
09/04/2008CA2677977A1 Comparative multiple analyte assay
09/04/2008CA2677901A1 Method for the assessment of the inhibitory activity of antibodies against insulin-like growth factor i receptor
09/04/2008CA2677075A1 Method for activation of helper t cell and composition for use in the method
09/04/2008CA2676041A1 Method for qualifying the variability of an effluent composition
09/04/2008CA2675495A1 Methods for improving culture vessel assays
09/04/2008CA2656537A1 Analyte determination utilizing mass tagging reagents comprising a non-encoded detectable label
09/03/2008EP1965213A2 Microarrays and uses therefor
09/03/2008EP1965212A1 Non-liquid phase type chemiluminescent enzyme immunoassay method and assay kit
09/03/2008EP1965211A1 METHOD OF DETECTING SUGAR CHAIN HAVING GlcNAc TRANSFERRED BY GnT-V
09/03/2008EP1965210A1 Interface device for sensor array and method of using the same
09/03/2008EP1965209A1 Kit for assaying active ingredient of termite controlling agent by using immunoassay method
09/03/2008EP1965205A1 Amino acid analysis method using mass spectrometer
09/03/2008EP1965201A1 Sensing member for detecting total cholesterol of blood sample
09/03/2008EP1965193A1 Method for determining the alcohol content of fluids
09/03/2008EP1964947A1 Mask set for microarray, method of fabricating mask set, and method of fabricating microarray using mask set
09/03/2008EP1964933A1 Electrochemical sensor, kit comprising said sensor and process for the production thereof
09/03/2008EP1964932A2 Directed evolution method
09/03/2008EP1964931A2 Method for predicting immune response to neoplastic disease based on mRNA expression profile in neoplastic cells and stimulated leukocytes
09/03/2008EP1964929A1 Hla-b genotyping method and kit based on real-time pcr
09/03/2008EP1964928A1 Quinones as mediators for photometric tests
09/03/2008EP1964927A1 Quinones as mediators for photometric tests
09/03/2008EP1964921A2 The high bone mass gene of 11q13.3
09/03/2008EP1964915A1 Blood-brain barrier in vitro model, pathologic blood-brain barrier in vitro model, drug screening method using the same, pathologic blood-brain barrier function analysis method and pathogenesis analysis method
09/03/2008EP1964852A1 Anti-ilt7 antibody
09/03/2008EP1964850A2 Compositions and methods for the treatment and diagnosis of breast cancer
09/03/2008EP1964849A2 Transfection complexes
09/03/2008EP1964837A1 Anti-tumor agent for multiple myeloma
09/03/2008EP1964574A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell
09/03/2008EP1964560A1 Use of inhibitors of the degradation of p27 for the treatment of cancer
09/03/2008EP1963865A2 Cholesterol sensor
09/03/2008EP1963864A1 Screening compounds for activity in modulating chloride ion transport
09/03/2008EP1963863A2 Method for localizing labels in a sample
09/03/2008EP1963862A2 Methods for predicting treatment response based on the expression profiles of protein and transcription biomakers
09/03/2008EP1963861A1 Rna helicase as marker for rare tumours
09/03/2008EP1963860A1 Cancer screening test
09/03/2008EP1963859A1 Method of discriminating at least two cell populations, and application
09/03/2008EP1963858A2 A bioassay and peptides for use therein
09/03/2008EP1963857A1 Detection of secreted lipase proteins from candida species
09/03/2008EP1963856A1 Method and apparatus for analyzing bioprocess fluids
09/03/2008EP1963855A1 Device for detecting analytes in fluid samples
09/03/2008EP1963854A2 Assay apparatuses, methods and reagents
09/03/2008EP1963853A2 Assay modules having assay reagents and methods of making and using same
09/03/2008EP1963852A1 Optochemical sensor and method of making the same
09/03/2008EP1963851A2 Method and system for phase-locked sequencing
09/03/2008EP1963849A2 Methods for prediction and prognosis of cancer, and monitoring cancer therapy
09/03/2008EP1963848A1 Micro-fluidic structures
09/03/2008EP1963847A1 Method and system for measurement of nitrite and nitric oxide release
09/03/2008EP1963846A2 Container with rfid device for storing test sensors
09/03/2008EP1963845A2 Single-point measurement of high-z additives in sheets
09/03/2008EP1963844A1 A method and a system for monitoring structural changes of a fiber web